Shortages in the US drug supply can hit “a lot of different patient populations with different drugs”, David Margraf, a Pharmaceutical Research Scientist at the University of Minnesota’s Center for Infectious Disease Research and Policy, said. “Many of them don’t get a lot of headline news because they’re very niche,” he added. The raw ingredients…